• Targeted Non-Viral Gene Delivery to Adipocytes Using ATS-9R

  2026-05-09

  This article explores the development and validation of ATS-9R, an adipocyte-targeted non-viral gene delivery system. The referenced study demonstrates selective, efficient gene silencing in mature adipocytes, offering a promising avenue for obesity and metabolic syndrome research and potential therapeutic applications.

• HyperPFU™ High-Fidelity DNA Polymerase: Practical PCR Guidan

  2026-05-08

  HyperPFU™ high-fidelity DNA polymerase enables robust PCR amplification of long or GC-rich templates where standard enzymes often fail due to low fidelity or processivity. It is best used for applications requiring blunt-ended, high-accuracy DNA fragments, such as cloning or sequencing, but should be avoided in workflows needing 3'-A overhangs or sticky ends.

• CGF Triggers ROS-Driven Mitochondrial Dysfunction in CRC Sup

  2026-05-08

  This study reveals that the natural compound Cya-Gly-Fer (CGF), derived from purple sweet potato, suppresses colorectal cancer (CRC) progression by inducing reactive oxygen species (ROS) production, metabolic reprogramming, and mitochondrial dysfunction. The findings highlight CGF’s potential as a novel therapeutic candidate and provide mechanistic insights into its impact on cell cycle arrest and apoptosis in CRC models.

• Technical Guide: HyperScribe™ T7 High Yield Cy3 RNA Labeling

  2026-05-07

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus addresses the challenge of generating high-yield, randomly Cy3-labeled RNA probes for fluorescence-based detection, such as in situ hybridization and Northern blotting. This kit is intended strictly for research workflows and is not suitable for diagnostic or clinical applications.

• Wortmannin in Ferroptosis and HCC: Mechanistic Precision for

  2026-05-07

  This thought-leadership article explores how Wortmannin—a potent, selective, and irreversible PI3K inhibitor—enables new mechanistic insights and experimental strategies to overcome ferroptosis resistance in hepatocellular carcinoma (HCC). Integrating evidence from recent oncology research with strategic guidance, the content guides translational scientists through protocol parameters, competitive benchmarking, and future directions while directly linking to authoritative resources and APExBIO’s Wortmannin product.

• Z-YVAD-FMK: Translating Caspase-1 Inhibition into Research I

  2026-05-06

  This thought-leadership article unpacks the mechanistic foundation and strategic utility of Z-YVAD-FMK, a potent caspase-1 inhibitor, for translational researchers tackling inflammation, cell death, and disease modeling. By weaving together recent findings, competitive benchmarks, and rigorous protocol guidance, we provide a roadmap for leveraging this tool in apoptosis and pyroptosis research, while highlighting the unique translational opportunities and limitations informed by state-of-the-art evidence.

• AM251: CB1 Receptor Antagonist Workflows for Translational R

  2026-05-06

  AM251 enables precision dissection of endocannabinoid signaling in both neuropharmacology and metabolic disorder models. This article provides protocol-driven guidance, troubleshooting, and practical insights for maximizing CB1 receptor antagonist utility in cutting-edge cannabinoid receptor research.

• FCCP: Advancing Immunometabolic Targeting for Translational

  2026-05-05

  This thought-leadership article explores the transformative role of FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) in immunometabolic modulation, focusing on mitochondrial uncoupling, HIF pathway inhibition, and the strategic reprogramming of tumor-associated macrophages. Integrating mechanistic insights from recent research, including 25-hydroxycholesterol-driven AMPK activation, we provide actionable guidance for translational researchers aiming to bridge metabolic biology and next-generation cancer therapies. APExBIO’s FCCP is emphasized as a rigorously validated, reproducible tool for dissecting metabolic regulation in both in vitro and in vivo settings.

• Applied Metabolism Research with the DiscoveryProbe Library

  2026-05-05

  Unlock high-throughput, pathway-specific metabolic insights with the DiscoveryProbe Metabolism-related Compound Library. This guide demonstrates optimized workflows, troubleshooting tactics, and translational applications, leveraging APExBIO’s rigorously validated panel of 493 cell-permeable compounds.

• Fangchinoline Restores TFEB-Driven Lysosomal Function in H1N

  2026-05-04

  This study uncovers fangchinoline as a potent modulator that restores TFEB-dependent lysosomal biogenesis, counteracting H1N1-induced lysosomal dysfunction and blocking viral entry. The findings highlight the therapeutic potential of lysosome-targeted strategies in antiviral research, with methodological implications for related pharmacology workflows.

• Bafilomycin C1: Precision V-ATPase Inhibitor for Autophagy A

  2026-05-04

  Bafilomycin C1 stands out as a gold-standard vacuolar H+-ATPases inhibitor for dissecting autophagy, apoptosis, and lysosomal function in translational research. Its high purity and predictable inhibition make it indispensable for high-content phenotypic screening, especially in iPSC-derived disease models where reproducibility and assay signal are paramount.

• TaqI Restriction Endonuclease: Rapid DNA Cleavage Protocols

  2026-05-03

  TaqI Restriction Endonuclease (SKU K3053) provides molecular biologists with a fast, reliable enzyme for precise DNA cleavage in cloning, PCR product analysis, and genomic DNA manipulation. Its rapid action and engineered buffer system streamline DNA digestion workflows, but should not be used for diagnostic or clinical applications due to intended research-only labeling.

• Busulfan as a DNA Alkylating Agent: Applied Protocols & Insi

  2026-05-02

  Busulfan’s precision as a DNA alkylating agent underpins its central role in modeling germ cell depletion and senescence in both cellular and animal systems. This article translates the latest dual recombinase-mediated tracing advances into actionable workflows, troubleshooting strategies, and protocol enhancements for maximum reproducibility. APExBIO provides the trusted foundation for reliable Busulfan supply in these demanding applications.

• DiD (DiDC 18 (5)) Probe: Precision Membrane Labeling in Macr

  2026-05-01

  Explore the advanced performance of DiD (DiDC 18 (5)) in macrophage and inflammatory research. This article provides a rigorous technical analysis and strategic application guidance, differentiating DiD from other membrane dyes for high-precision cell membrane staining.

• Chloramphenicol in Molecular Biology: Applied Workflows & Tr

  2026-05-01

  Chloramphenicol, a potent bacterial protein synthesis inhibitor, is indispensable for advanced molecular biology workflows—especially in stringent plasmid selection and resistance gene transfer studies. This article translates new resistance gene insights into practical protocols, troubleshooting, and comparative guidance for maximizing reproducibility and specificity with APExBIO’s high-purity Chloramphenicol.

11372 records 1/759 page Next 12345 下5页 Last page